Altered angiotensin-converting enzyme 2 (ACE2) receptor expression, which has been seen in lung injury during COVID-19, has also been observed in the gut, across numerous studies (Jin et al. 2021), leading to leaky gut and microbiome dysbiosis (Penninger et al. 2021), among other disorders. This evidence concerns the gene ACE2 and COVID-19.